Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

BMC Cancer

Topics

Economics

Cancer Oncology

Medicine

Internal Medicine

Surgery

Show all topics

DOI

10.1186/s12885-019-5977-6

License

CC-BY

Other Formats

PDF